(Q36237854)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115586%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Osteoporosis screening of postmenopausal women in the primary care setting: a case-based approach (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115586%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115586%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Ellen R Brooks

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115586%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Craig B Langman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115586%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

1 reference

1 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115586%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115586%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115586%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115586%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

70-85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115586%20AND%20SRC:MED&resulttype=core&format=json

Osteoporosis prevention, diagnosis, and therapy

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Perspective. How many women have osteoporosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Mortality and morbidity after hip fractures

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Risk of Mortality Following Clinical Fractures

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Risk factors for hip fracture in middle-aged Norwegian women and men

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Risks of perimenopausal fractures--a prospective population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Treatable and untreatable risk factors for hip fracture

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Family history and risk of osteoporotic fracture. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Smoking and mortality among older women: the study of osteoporotic fractures

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Body size and hip fracture risk in older women: a prospective study. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Physical activity and osteoporotic fracture risk in older women. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Position statement : executive summary. The Writing Group for the International Society for Clinical Densitometry (ISCD) Position Development Conference

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Psychological and behavioural effects of bone density screening for osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Validation of OSIRIS, a prescreening tool for the identification of women with an increased risk of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Association of osteoporotic vertebral compression fractures with impaired functional status

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Cytokines and bone loss in a 5-year longitudinal study--hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

The relative contributions of age and years since menopause to postmenopausal bone loss.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Fractures between the ages of 20 and 50 years increase women's risk of subsequent fractures

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Forearm fractures as predictors of subsequent osteoporotic fractures

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Long-Term Observations on the Loss of Bone Mineral Following Colles' Fracture

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Awareness of osteoporosis and compliance with management guidelines in patients with newly diagnosed low-impact fractures

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal. Alendronate Osteoporosis Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Short-term and long-term fracture prediction by bone mass measurements: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Vertebral fractures in osteoporosis: a new method for clinical assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Assessment of prevalent and incident vertebral fractures in osteoporosis research

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

The effect of overlying calcification on lumbar bone densitometry

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Lateral dual-energy radiography: artifact error from rib and pelvic bone

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Ultrasound Measurements for the Prediction of Osteoporotic Fractures in Elderly People

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Hypovitaminosis D in Medical Inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

McCollum Award Lecture, 1994: vitamin D--new horizons for the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Correcting calcium nutritional deficiency prevents spine fractures in elderly women.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Age considerations in nutrient needs for bone health: older adults

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Changes in musculoskeletal structure and function with prolonged bed rest

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Effects of 1- and 6-month spaceflight on bone mass and biochemistry in two humans

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

American College of Sports Medicine position stand. Progression models in resistance training for healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Dietary supplements and physical exercise affecting bone and body composition in frail elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Does multiple risk factor reduction explain the reduction in fall rate in the Yale FICSIT Trial? Frailty and Injuries Cooperative Studies of Intervention Techniques

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Alcohol abuse and osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Treatment of postmenopausal osteoporosis with transdermal estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Failure of estrogen plus progestin therapy for prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Postmenopausal hormone replacement therapy: scientific review

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

Does follow-up of osteoporotic women treated with antiresorptive therapies improve effectiveness?

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2804%2980013-5

7 January 2021

10.1016/S1550-8579(04)80013-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115586%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference